Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation

Transplant International

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Van Den Berg, A P ^a   Klompmaker, I J ^a   Hepkema, B G ^a   Gouw, A S H ^a   Haagsma, E B ^a   Lems, S P ^a   The, T H ^a   Slooff, M J H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cytomegalovirus; HLA DR; Liver transplantation; VBDS

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GANCICLOVIR; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE;

ARTICLE; BILE DUCT DISEASE; BIOASSAY; CYTOMEGALOVIRUS INFECTION; EARLY DIAGNOSIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL TIME;

EID: 0029853909     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb01599.x     Document Type: Article

References (8)

1. O'Grady JG, Alexander GJM, Sutherland S, et al (1988) Lancet 2: 302-305
2. Manez R, White LT, Linden P, et al (1993) Transplantation 55: 1067-1071
3. Paya CV, Wiesner RH, Hermans PE, et al (1992) Hepatology 16: 66-70
4. Van der Bij W, Torensma R, Van Son WJ, et al (1988) J Med Virol 25: 179-188
5. Van den Berg AP, Klompmaker IJ, Haagsma EB, et al (1991) J Infect Dis 164: 265-270
6. Klompmaker IJ, Haagsma EB, Gouw ASH, et al (1989) Transplantation 48: 814-818
7. Rood van JJ, Leeuwen van A, Ploem JS (1976) Nature 262: 795-797
8. Portmann B, Neuberger J, Williams R (1983) In: Calne RY (ed) Liver transplantation. Grune & Stratton, New York, pp 279-287